Cannabidiol

LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show.

LOS ANGELES — Treatment with cannabidiol in young people with tuberous sclerosis complex led to significant improvements in several cognitive, behavioral and executive domains, data from ongoing survey show.

Topically applied nanoparticle-encapsulated cannabidiol cream helped prevent and repair damage to the skin from ultraviolet A radiation, according to a first-of-its-kind study.

Researchers said that toxic metals, including lead, cadmium and arsenic, were found in 100% of the tampons they tested in a recent study.

Twenty percent of pregnant women reported using CBD-only products during pregnancy despite limited available data on potential adverse outcomes of CBD, according to findings published in Obstetrics & Gynecology.

DENVER — Treatment with cannabidiol led to significant seizure reduction in those with focal-onset epilepsy and demonstrated a favorable safety profile, according to research presented at the American Academy of Neurology annual meeting.

Quolet Industries has announced the completion of a phase 1 study evaluating a novel, lipid formulation of pure CBD as a potential treatment for various psychiatric and neurologic conditions.

SAN FRANCISCO — According to results presented here, cannabidiol may be effective in perioperative pain control for patients who previously underwent arthroscopic rotator cuff repair.

Caregivers for those with Lennox Gastaut and Dravet syndrome reported that cannabidiol treatment led to improved nonseizure outcomes and reduced seizure burden, according to a study from Epilepsy Research.

An umbrella review published in The BMJ provided a breakdown of the associations between cannabis and health outcomes, highlighting the uncertain potential for clinical use.